DEPARTMENT OF HEALTH AND HUMAN SERVICES An Overview of the Defense Medical Surveillance System The DMSS Project Laura H. Franzke, PhD, MPH National Immunization.

Slides:



Advertisements
Similar presentations
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDAs website for reference purposes only. It.
Advertisements

Presentation of ECDC, modelling networks and data availability
2010 Food Safety Epidemiology Capacity Assessment CSTE Annual Conference June 13, 2011 Lauren Rosenberg, MPA Council of State and Territorial Epidemiologists.
Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,
The Brighton Collaboration: An Overview and Preparedness for Pandemic Influenza Jane Gidudu MD, MPH Team leader April Compingbutra MPH, Paige Lewis MPH.
TEXAS SOUTHERN UNIVERSITY INSTITUTIONAL ANIMAL CARE AND USE PROGRAM WORKSHOP OFFICE OF RESEARCH LINDA M. GARDINER, Ph.D. DIRECTOR RESEARCH ENHANCEMENT.
North Carolina’s Role in Preparedness. Objectives How you fit into the LRN Describe critical aspects of lab preparedness, surveillance and reporting,
Public and Private Interests in Animal Research LAT Chapter 1.
Data and Information Management of the Smallpox Vaccine Program Department of Health and Human Services Centers for Disease Control and Prevention December.
NATIONAL ACADEMY OF SCIENCES NATIONAL RESEARCH COUNCIL Research Priorities: Earth Sciences and Public Health Board on Earth Sciences and Resources Board.
ENHANCED SURVEILLANCE OF NOVEL H1N1 VACCINES AMONG MILITARY PERSONNEL VRBPAC Meeting LTC Patrick Garman, PharmD, PhD Deputy Director for Scientific Affairs.
Center for Biologics Evaluation and Research Applying Regulatory Science to Advance Development of Innovative, Safe and Effective Biologic Products Carolyn.
RADM Ali S. Khan, MD, MPH Director, Office of Public Health Preparedness and Response Bridging the Gaps: Public Health and Radiation Emergency Preparedness.
FDA/CBER Role in Smallpox Vaccine Safety Bob Ball, MD, MPH, ScM Chief, Vaccine Safety Branch Office of Biostatistics and Epidemiology CBER, FDA January.
Center for Biologics Evaluation and Research FDA Overview Site Visit Carolyn A. Wilson, Ph.D. Associate Director for Research.
CVEP Symposium: Global Vaccines 202X: Access, Equity, Ethics 2-4 May 2011 The Franklin Institute Science Museum. Philadelphia, USA Global Vaccines 202X:
University of Hawaii Clinical Research Center Louise Medina, R.N., M.H.A. Clinical Program Administrator.
Health Departments and Healthcare-Associated Infection Prevention Research: A New Land of Opportunity? Matthew Wise, MPH, PhD Epidemiologist, Office of.
ONC Policy and Program Update Health IT Standards Committee Meeting July 17, 2013 Jodi Daniel Director, Office of Policy and Planning, ONC 0.
Environmental & Injury Epidemiology and Toxicology Unit Environmental Epidemiology and Disease Registries Section Prevention and Preparedness Division.
ONC Policy and Program Update Health IT Policy Committee Meeting July 9, 2013 Jodi Daniel Director, Office of Policy and Planning, ONC 0.
Internal Auditing and Outsourcing
The National Vaccine Plan Process - Update October 22, 2007 Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services.
Epidemiology Tools and Methods Session 2, Part 1.
EXPERIENCES OF AN EXTERNAL PREVENTION SERVICE IN OCCUPATIONAL HEALTH WITH A MEDICAL ETHICS COMMITTEE G. MOENS, S. BULTERYS IDEWE, External Service for.
DEPARTMENT OF HEALTH AND HUMAN SERVICES Monitoring Anthrax Vaccine Adverse Events Defense Medical Surveillance System (DMSS) Michael McNeil, MD, MPH National.
Performance Standards: Opportunities for Quality Improvement for Maternal and Child Health Dennis Lenaway, PhD, MPH Centers for Disease Control and Prevention.
5 March 2012 Full-time Support Review of the Reserve Components Phase 1: An analysis of and report for Congress on the Military Technician (MilTech) Program.
DEPARTMENT OF HEALTH AND HUMAN SERVICES Monitoring Anthrax Vaccine Adverse Events Defense Medical Surveillance System (DMSS) Michael McNeil, MD, MPH National.
Emergency Responder Health Monitoring and Surveillance “ERHMS” John Halpin, M.D., MPH and Renee Funk DVM, MPH
1 ESSENCE: Biosurveillance in Support of the DoD Health Mission.
Needs and Recommendations for the United States Poliovirus Vaccine Stockpile Report of the Joint Working Group of the National Vaccine Advisory Committee.
RESEARCH PROGRAM UPDATE Sarah Castro, MPH Senior Research Support Liaison.
FDA’s Draft LDT Framework & Personalized Medicine Update
Strategic Issues in Vaccine Research (SIVR) Program Update, 2007 Ben Schwartz, NVPO NVAC June 2007.
University of Iowa Cancer Prevention and Control Research Network Sue Curry, Ph.D., Principal Investigator This presentation was supported by Cooperative.
Immunization Safety Review: Vaccines and Autism Marie McCormick Chair, Immunization Safety Review Committee Presentation to NVAC June 2004.
Center for Biologics Evaluation and Research Carolyn A. Wilson, Ph.D. Associate Director for Research Applying Regulatory Science to Advance Development.
Subcommittee on Vaccine Safety Subcommittee on Public Communication, Consultation and Participation June7, 2007.
Shirley Haberman, PhD, CHES Jane Emmeree, PhD, CHES From Content to Process: The Transition of a Health Promotion Department.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
National Vaccine Advisory Committee Report from the Chair Gus Birkhead, MD, MPH NVAC Chair June 2, 2010.
National Vaccine Advisory Committee Report from the Chair Gus Birkhead, MD, MPH NVAC Chair February 3, 2010.
CIFOR Council to Improve Foodborne Outbreak Response CIFOR Guidelines and CIFOR Toolkit Donald J. Sharp, MD, DTM&H Food Safety Office National Center for.
Smallpox Vaccine Safety and Reporting Adverse Events Department of Health and Human Services Centers for Disease Control and Prevention December 2002.
(Slide 1 of 22) Response to the National Vaccine Advisory Committee Recommendations on the Immunization Safety Office Scientific Agenda Frank DeStefano,
Strategies to Consider to Improve ACCV Effectiveness Presentation to ACCV Vito Caserta M.D., M.P.H. Vincent Matanoski, J.D. December 5,
1 Preparedness to Monitor Safety of the Pandemic (H1N1) 2009 Vaccines VRBPAC July 23, 2009 Presented by Hector S. Izurieta CBER/FDA.
An Overview: The Role of the Audit Committee in Monitoring, Oversight, and Compliance Derry Harper, Inspector General and Director of Compliance.
FDA Science Board CDER Drug Safety Update November 6, 2005 Rockville, MD Steven Galson, MD, MPH Director, Center for Drug Evaluation and Research Food.
Summary of the Advisory Committee on Blood and Tissue Safety and Availability 47 th Meeting Jim Berger, ACBTSA Designated Federal Officer November 9 -
NVAC H1N1 Vaccine Safety Risk Assessment Working Group (VSRAWG) Update NVAC Meeting June 2, 2010 Marie McCormick, M.D., Sc.D. Sumner and Esther Feldberg.
Evaluation Plan Steven Clauser, PhD Chief, Outcomes Research Branch Applied Research Program Division of Cancer Control and Population Sciences NCCCP Launch.
Office of Core and Shared Resources Faculty Council Meeting October 9, 2012.
IOM Review: VSD Data Sharing Program Melinda Wharton, M.D. National Immunization Program, CDC NVAC Vaccine Safety Subcommittee October 5, 2004.
Emerging SACHRP Issues K. Lynn Cates, MD Assistant Chief Research & Development Officer Director, PRIDE Office of Research & Development Department of.
Vaccine Safety Research, Data Access, and Public Trust Findings and Recommendations from IOM NVAC Meeting June 8, 2005 Debra Lappin, J.D. Senior Advisor,
NVAC Vaccine Safety Risk Assessment Working Group (VSRAWG) Update NVAC Meeting February 3, 2010 Marie McCormick, M.D., Sc.D. Sumner and Esther Feldberg.
IOM Committee on DHS Occupational Health & Operational Medicine Infrastructure Federal Occupational Health Services Gene Migliaccio, DrPH, Director Herman.
H1N1 Vaccine Safety Subgroup: Draft Recommendations to NVAC NVAC Teleconference July 27, 2009 Daniel Salmon Vaccine Safety Specialist National Vaccine.
Data Coordinating Center University of Washington Department of Biostatistics Elizabeth Brown, ScD Siiri Bennett, MD.
Department of Legal Medicine Armed Forces Institute of Pathology
National Immunization Conference April 19, 2010
MILTECH Study Update LtCol PJ Zimmerman, USMC
National Immunization Conference
Active Cumbria Governance Structure
Professional Organizations
Allen Chan U.S. Government Accountability Office October 2, 2018
Framework for Analysis of Multiple Near-Simultaneous Vaccinations and U.S. Military Hospitalizations Charles Rose, PhD Daniel Payne, PhD, MSPH.
Updating the National Vaccine Plan: A roadmap for the next decade A National, not Federal, Plan December 11, 2009.
Presentation transcript:

DEPARTMENT OF HEALTH AND HUMAN SERVICES An Overview of the Defense Medical Surveillance System The DMSS Project Laura H. Franzke, PhD, MPH National Immunization Program NVAC, June 4 th, 2003

DEPARTMENT OF HEALTH AND HUMAN SERVICES Background  CDC was charged by Congress to undertake collaborative studies regarding the safety and efficacy of the anthrax vaccine adsorbed (AVA)  NIP is working collaboratively with the DoD and FDA to investigate potential adverse events associated with AVA using the DoD’s Defense Medical Surveillance System (DMSS) database

DEPARTMENT OF HEALTH AND HUMAN SERVICES Purpose  To perform hypothesis testing and hypothesis generation with the DMSS  Examine the possibility that long term adverse effects are associated with AVA

DEPARTMENT OF HEALTH AND HUMAN SERVICES Institute of Medicine (An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program, IOM of the National Academies, 2003)  “HIGH PRIORITY: Linkages of the Defense Medical Surveillance Systems and other databases for longer-term follow-up of military personnel who received AVA”

DEPARTMENT OF HEALTH AND HUMAN SERVICES DMSS Structure and Functional Relationships (Adapted from: AJPH, Dec 2002, Vol 92, No. 12) Personnel Data  Active Duty  Reserve Component  Active Duty Casualty  Military Entrance  Processing Stations DMSS

DEPARTMENT OF HEALTH AND HUMAN SERVICES DMSS Structure and Functional Relationships (Adapted from: AJPH, Dec 2002, Vol 92, No. 12) Personnel Data DMSS Medical Data  In-patient  Ambulatory  Reportable Events  Immunizations

DEPARTMENT OF HEALTH AND HUMAN SERVICES DMSS Structure and Functional Relationships (Adapted from: AJPH, Dec 2002, Vol 92, No. 12) DMSS Serologic Data  Serum Specimens Personnel Data Medical Data

DEPARTMENT OF HEALTH AND HUMAN SERVICES

DMSS Structure and Functional Relationships (Adapted from: AJPH, Dec 2002, Vol 92, No. 12) DMSS Personnel Data Medical Data Serologic Data Deployment Data  Deployment Rosters  Pre/Post Health Assessment  Disease & non-battle injury (aggregate)

DEPARTMENT OF HEALTH AND HUMAN SERVICES DMSS Structure and Functional Relationships (Adapted from: AJPH, Dec 2002, Vol 92, No. 12) MSMR Ad hoc Requests Studies/Analyses Reports Defense Medical Epidemiology Database (DMED) DMSS Personnel Data Medical Data Serologic Data Deployment Data

DEPARTMENT OF HEALTH AND HUMAN SERVICES Medical Surveillance Monthly Report (MSMR) DMED: Defense Medical Epidemiological Database

DEPARTMENT OF HEALTH AND HUMAN SERVICES  AMSA: Army Medical Surveillance Activity  FOH: Federal Occupational Health  VAU: Vaccine Analytic Unit  Internal Steering Committee: CDC, DoD, FDA  External Consultative Committee:  National Vaccine Advisory Committee

DEPARTMENT OF HEALTH AND HUMAN SERVICES DMSS Project Organizational Structure Internal Steering Committee AMSA FOH Hiring & Administrative Support Vaccine Analytic Unit (VAU) CDC/DoD/FDA DMSS IRBs DATA Outside External Consultative Committee

DEPARTMENT OF HEALTH AND HUMAN SERVICES Mission for the External Consultative Committee  The External Consultative Committee will act as an “Advisory” scientific committee providing expert advice regarding the development and growth for the DMSS Project.

DEPARTMENT OF HEALTH AND HUMAN SERVICES Roles and Responsibilities for the External Consultative Committee  Make recommendations about priority hypotheses to study  Provide advice and comment on study protocols  Periodically updated about study procedures and progress  Review results from analyses of DMSS data  Provide advice on study results manuscripts and dissemination

DEPARTMENT OF HEALTH AND HUMAN SERVICES External Consultative Committee  Time Commitment: 3-5 years  Meetings: Twice a year in-person (during NVAC meetings) and occasionally by teleconference  Members: Requesting approximately 5 members from NVAC  Expertise: Epidemiology, internal medicine, immunology, vaccine safety, military medicine

DEPARTMENT OF HEALTH AND HUMAN SERVICES Acknowledgements DOD Mark Rubertone John Grabenstein John Brundage Jeff Lange DMSS Staff CDC Ben Schwartz Mike McNeil Bruce Tierney Phil Rhodes Stacey Martin Paul Stehr-Green Betsy Cadwell Roseanne English- Bullard Kelly Bell FDA Bob Ball Dale Burwen Jane Woo FOH Wayne Grant Richard Horn AVEC